Skip to content
TrialScanner

NCT04402866

TD-0903 for ALI Associated With COVID-19

Phase 2CompletedTBPHLead

Registry record

Lead sponsor
Theravance Biopharma
Conditions
Acute Lung Injury (ALI) Associated With COVID-19; Lung Inflammation Associated With COVID-19
Primary completion
Apr 21, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04402866 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04402866: TD-0903 for ALI Associated... | TrialScanner